CAM
AMRI

Capstone Asset Management’s Albany Molecular Research Inc AMRI Stock Holding History

Capstone Asset Management’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-16,780
Closed -$277K – 1667
2016
Q3 		$277K Sell
16,780
-170
-1% -$2.52K 0.01% 1358
2016
Q2 		$228K Buy
16,950
+2,610
+18% +$38.1K 0.01% 1451
2016
Q1 		$219K Sell
14,340
-40
-0.3% -$627 0.01% 1449
2015
Q4 		$285K Buy
14,380
+1,170
+9% +$22.2K 0.01% 1311
2015
Q3 		$230K Buy
13,210
+1,120
+9% +$22.8K 0.01% 1403
2015
Q2 		$244K Sell
12,090
-5,350
-31% -$103K 0.01% 1412
2015
Q1 		$307K Buy
17,440
+570
+3% +$9.71K 0.01% 1385
2014
Q4 		$275K Buy
16,870
+6,990
+71% +$128K 0.01% 1419
2014
Q3 		$218K Buy
+9,880
New +$202K 0.01% 1528

Other funds holding AMRI

PIP
Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
OWP
Obermeyer Wealth Partners Aspen, Colorado $2.17B AUM 19.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ACM
American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

Capstone Asset Management's AMRI Position: Q4 2016 in Review

Capstone Asset Management sold out of Albany Molecular Research Inc (AMRI) in Q4 2016, closing a stake of 16,780 shares — an estimated $277K sold.

Capstone Asset Management first reported a position in AMRI in Q3 2014 and held it in 9 quarters. The position peaked at $307K in Q1 2015. 133 funds tracked by Wall St. Rank hold AMRI as of Q4 2016.

  • Capstone Asset Management reported no remaining Albany Molecular Research Inc position as of Q4 2016 after selling out during the quarter.
  • Capstone Asset Management sold 16,780 Albany Molecular Research Inc shares in Q4 2016, an estimated $277K.
  • Capstone Asset Management first reported a position in Albany Molecular Research Inc in Q3 2014 and held it in 9 quarters.
  • Capstone Asset Management's Albany Molecular Research Inc position peaked at $307K in Q1 2015.
  • 133 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q4 2016.

Based on Capstone Asset Management's 13F filing for Q4 2016, filed 17 Jan 2017.